BackgroundDerailment of proteostasis, the homeostasis of production, function, and breakdown of proteins, contributes importantly to the selfâperpetuating nature of atrial fibrillation (AF), the most common heart rhythm disorder in humans. Autophagy plays an important role in proteostasis by degrading aberrant proteins and organelles. Herein, we investigated the role of autophagy and its activation pathway in experimental and clinical AF.Methods and ResultsTachypacing of HLâ1 atrial cardiomyocytes causes a gradual and significant activation of autophagy, as evidenced by enhanced LC3BâII expression, autophagic flux and autophagosome formation, and degradation of p62, resulting in reduction of Ca2+ amplitude. Autophagy is activated downstream of endoplasmic reticulum (ER) stress: blocking ER stress by the chemical chaperone 4âphenyl butyrate, overexpression of the ER chaperoneâprotein heat shock protein A5, or overexpression of a phosphorylationâblocked mutant of eukaryotic initiation factor 2α (eIF2α) prevents autophagy activation and Ca2+âtransient loss in tachypaced HLâ1 cardiomyocytes. Moreover, pharmacological inhibition of ER stress in tachypaced Drosophila confirms its role in derailing cardiomyocyte function. In vivo treatment with sodium salt of phenyl butyrate protected atrialâtachypaced dog cardiomyocytes from electrical remodeling (action potential duration shortening, Lâtype Ca2+âcurrent reduction), cellular Ca2+âhandling/contractile dysfunction, and ER stress and autophagy; it also attenuated AF progression. Finally, atrial tissue from patients with persistent AF reveals activation of autophagy and induction of ER stress, which correlates with markers of cardiomyocyte damage.ConclusionsThese results identify ER stressâassociated autophagy as an important pathway in AF progression and demonstrate the potential therapeutic action of the ERâstress inhibitor 4âphenyl butyrate.